Literature DB >> 2693607

The lipid composition and permeability to the triazole antifungal antibiotic ICI 153066 of serum-grown mycelial cultures of Candida albicans.

C A Hitchcock1, K J Barrett-Bee, N J Russell.   

Abstract

The total lipid content of Candida albicans (serotype A: NCPF 3153) exponential-phase mycelial cultures grown in tissue-culture medium 199 (containing 10%, v/v, foetal calf serum) was 29.8 +/- 8 mg (g dry weight)-1 (mean +/- SD). The weight ratios of phospholipid to neutral lipid and phospholipid to non-esterified sterol were 2.6 +/- 0.4 and 24.9 +/- 0.5, respectively. The major phospholipid was phosphatidylcholine with smaller amounts of phosphatidylethanolamine, phosphatidylinositol, phosphatidylserine, phosphatidylglycerol and diphosphatidylglycerol; the most abundant fatty acids were palmitic, palmitoleic, oleic and linoleic acids. The major neutral lipids comprised esterified sterol, triacylglycerol and non-esterified fatty acid with a smaller amount of non-esterified sterol. The fatty acid compositions of the three fatty-acid-containing neutral lipids were distinct from each other and the phospholipids. Comparison with previous data on yeast cultures of C. albicans A grown in glucose broth shows that mycelial cultures have a larger lipid content, lower phospholipid to neutral lipid ratio and higher phospholipid to non-esterified sterol ratio. We now show that mycelial cultures were more permeable to a [14C]triazole antifungal antibiotic compared with exponentially growing yeast cultures of several azole-sensitive strains. Taken together these data are consistent with there being a relationship between the phospholipid/non-esterified sterol ratio of a culture and its ability to accumulate a triazole.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693607     DOI: 10.1099/00221287-135-7-1949

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  10 in total

1.  Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.

Authors:  N D Lees; M C Broughton; D Sanglard; M Bard
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

2.  Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.

Authors:  R C Hahn; J S Hamdan
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Triazole-Linked Glycolipids Enhance the Susceptibility of MRSA to β-Lactam Antibiotics.

Authors:  Xi-Le Hu; Dan Li; Lei Shao; Xiaojing Dong; Xiao-Peng He; Guo-Rong Chen; Daijie Chen
Journal:  ACS Med Chem Lett       Date:  2015-06-01       Impact factor: 4.345

4.  Fluconazole resistance in Candida glabrata.

Authors:  C A Hitchcock; G W Pye; P F Troke; E M Johnson; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  Use of cilofungin as direct fluorescent probe for monitoring antifungal drug-membrane interaction.

Authors:  Y T Ko; R D Ludescher; D J Frost; B P Wasserman
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

6.  Potentiation of azole antifungals by 2-adamantanamine.

Authors:  Michael D Lafleur; Lingmei Sun; Ida Lister; John Keating; Andre Nantel; Lisa Long; Mahmoud Ghannoum; Jeffrey North; Richard E Lee; Ken Coleman; Thomas Dahl; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

7.  Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.

Authors:  Pranab K Mukherjee; Jyotsna Chandra; Duncan M Kuhn; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

Authors:  D Sanglard; K Kuchler; F Ischer; J L Pagani; M Monod; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

9.  Anti-Candida activity of 1-18 fragment of the frog skin peptide esculentin-1b: in vitro and in vivo studies in a Caenorhabditis elegans infection model.

Authors:  Vincenzo Luca; Massimiliano Olivi; Antonio Di Grazia; Claudio Palleschi; Daniela Uccelletti; Maria Luisa Mangoni
Journal:  Cell Mol Life Sci       Date:  2013-11-10       Impact factor: 9.261

Review 10.  Combination Therapy to Treat Fungal Biofilm-Based Infections.

Authors:  Jana Tits; Bruno P A Cammue; Karin Thevissen
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.